共 6 条
[1]
[2]
Orlistat; a novel potent antitumor agent for ovarian cancer: proteomicanalysis of ovarian cancer cells treated with Orlistat[J] Hui-Qiong Huang;Jing Tang;Sheng-Tao Zhou;Tao Yi;Hong-Ling Peng;Guo-Bo Shen;Na Xie;Kai Huang;Tao Yang;Jin-Hua Wu;Can-Hua Huang;Yu-Quan Wei;Xia Zhao International Journal of Oncology 2012,
[3]
Effects of liraglutide in the treatment of obesity: a randomised; double-blind; placebo-controlled study[J] The Lancet 2009,
[4]
Inhibition of Fatty Acid Synthase by Orlistat Accelerates Gastric Tumor Cell Apoptosis in Culture and Increases Survival Rates in Gastric Tumor Bearing Mice In Vivo[J] Shawn Dowling;James Cox;Richard J. Cenedella Lipids 2009,
[5]
Efficacy and Safety Comparison of Liraglutide; Glimepiride; and Placebo; All in Combination With Metformin; in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study[J] Nauck; Michael;Frid; Anders;Hermansen; Kjeld;Shah; Nalini S;Tankova; Tsvetalina;Mitha; Ismail H;Zdravkovic; Milan;Düring; Maria;Matthews; David R Diabetes Care 2009,
[6]
Use of sibutramine in obese mexican adolescents: A 6-month; randomized; double-blind; placebo-controlled; parallel-group trial[J] Leticia M. García-Morales;Arturo Berber;Cecilia C. Macias-Lara;Claudia Lucio-Ortiz;Blanca E. Del-Rio-Navarro;Luis M. Dorantes-Alvárez Clinical Therapeutics 2006,